Earnings Ahead

VKTX - VIKING THERAPEUTICS INC.

14.835 -3.305 -18.22

VIKING THERAPEUTICS INC.

VIKING THERAPEUTICS INC.

About

Profile


Headquarters

California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

VKTX

The drugmaker soared 7% after announcing promising results from its experimental VK2735 obesity pill, including weight loss of up to 8.2% within a four-week period. The drug is classified as a GLP-1, which could put the company in competition with Novo Nordisk and Eli Lilly.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Viking Therapeutics GAAP EPS of -$0.25 beats by $0.01
  • Viking Therapeutics Q4 2023 Earnings Preview
  • Eli Lilly hurts NASH drug developers after mid-stage win for obesity therapy
  • Viking Therapeutics gains amid takeover speculation
  • Barron’s cites cancer and weight loss plays for biotech M&A
  • J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up
  • Viking Therapeutics rises on Roche acquiring peer Carmot
  • Pfizer hits new 52-week low after weight loss setback
  • Viking Therapeutics stock climbs as liver drug shows efficacy among key patient subgroups
  • Viking Therapeutics GAAP EPS of -$0.23 misses by $0.01
  • Viking Therapeutics Q3 2023 Earnings Preview
  • Biggest stock movers today: Morgan Stanley, Spirit AeroSystems, United Airlines and more
  • Viking Therapeutics rises after Phase 1 data for weight loss therapy
  • Drugmakers still chasing potentially lucrative NASH market, despite setbacks
  • Watch weight loss stocks after cardiovascular data for Wegovy
  • Nearly half of U.S. adults want weight-loss drugs – KFF poll
  • Viking Therapeutics files for mixed shelf offering
  • Viking Therapeutics GAAP EPS of -$0.19 in-line
  • Viking Therapeutics Q2 2023 Earnings Preview
  • Viking Therapeutics gains as Street defends after selloff

Earnings History

Date EPS / Forecast Revenue / Forecast
February 9, 2022 -0.16 / -0.188 - / -
November 3, 2021 -0.17 / -0.21 - / -
July 28, 2021 -0.2 / -0.1962 - / -
April 28, 2021 -0.19 / -0.1736 - / -
February 17, 2021 -0.15 / -0.1524 - / -
October 28, 2020 -0.13 / -0.152 - / -
April 30, 2020 -0.13 / -0.12 - / -
February 26, 2020 -0.1 / -0.13 - / -
Date Price Open High Low Vol Change
Nov 20 51.53 52.7
53.01
50.44
3.5M 0.04%
Nov 19 51.51 48.75
51.68
47.85
5.5M 4.89%
Nov 18 49.11 49.1
50.51
47.65
4.8M -0.95%
Nov 15 49.58 53.18
53.2
48.98
8.1M -7.45%
Nov 14 53.57 55
56
53.56
3.9M -2.71%
 
Nov 13 55.06 61.23
61.23
54.54
6.9M -9.14%
Nov 12 60.6 62.46
62.5
57.37
8.3M -3.76%
Nov 11 62.97 68.8
68.87
62.81
4.6M -8.05%
Nov 8 68.48 68.74
70.41
65.77
3.9M -0.54%
Nov 7 68.85 66.1
69.1
64.8
3.9M 4.52%
Nov 6 65.87 65.59
66.38
62.8
5.9M 1.92%
Nov 5 64.63 63.53
67.73
62.5
8.5M 2.36%
Nov 4 63.14 78.3
79.1
62.8
29.6M -13.36%
Nov 1 72.88 73.67
75.28
72.45
3.2M 0.47%
Oct 31 72.54 71.37
74.06
70.57
3.4M 1.10%
Oct 30 71.75 71
74.81
70.1
4.0M -2.18%
Oct 29 73.35 74
74.03
71.37
3.4M -1.57%
Oct 28 74.52 79.03
81.73
74.15
6.2M -4.5%
Oct 25 78.03 74
81.04
73.15
9.2M 6.57%
Oct 24 73.22 65.75
75.67
63.67
16.4M 21.25%
Oct 23 60.39 61.61
62.63
60.01
3.2M -2.64%
Oct 22 62.03 64.25
65.04
61.6
2.8M -3.59%
Oct 21 64.34 65.26
66.27
63.83
1.7M -2.22%
Oct 18 65.8 65.12
66
64.42
1.5M 1.84%
Oct 17 64.61 65.89
66.59
64.57
1.5M -1.88%
Oct 16 65.85 65.82
67.31
64.91
1.5M 0.72%
Oct 15 65.38 65.8
67.67
64.7
1.5M -0.64%
Oct 14 65.8 65.34
66.94
63.6
1.8M -0.06%
Oct 11 65.84 62.78
66.42
62.47
3.3M 5.43%
Oct 10 62.45 62
62.89
61.3
2.0M -0.3%
Oct 9 62.64 67.16
67.5
62.43
3.4M -6.06%
Oct 8 66.68 63.7
68.74
63.25
3.4M 5.82%
Oct 7 63.01 65.61
66.28
62.94
1.5M -3%
Oct 4 64.96 64.75
65.67
62.57
2.1M 1.33%
Oct 3 64.11 64.6
66.38
63.44
1.9M -0.9%
Oct 2 64.69 62
64.85
61.18
1.7M 4.34%
Oct 1 62 63.22
63.78
60.57
2.2M -2.07%
Sep 30 63.31 61.9
64.55
61.41
2.1M 2.73%
Sep 27 61.63 62.51
63.22
61.29
1.8M -1.11%
Sep 26 62.32 63.13
63.99
61.39
1.8M -1.28%
Sep 25 63.13 62.69
65.61
62.23
3.0M 1.94%
Sep 24 61.93 64.64
64.83
61.59
3.7M -4.74%
Sep 23 65.01 70.64
70.64
64.61
3.6M -7.75%
Sep 20 70.47 69.5
72.36
68.51
8.0M 3.39%
Sep 19 68.16 66.27
68.2
65.18
2.6M 5.76%
Sep 18 64.45 63.05
66.05
62.62
2.3M 2.40%
Sep 17 62.94 66.12
67.06
62.2
3.5M -6.2%
Sep 16 67.1 66.21
68.83
64.54
2.9M 0.55%
Sep 13 66.73 63.08
67.94
62.63
3.7M 6.24%
Sep 12 62.81 62.71
64.66
62.06
4.1M 3.25%
Sep 11 60.83 57.23
61.11
55.92
5.6M 11.31%
Sep 10 54.65 54.73
55.35
52.7
1.6M -0.24%
Sep 9 54.78 56.29
56.37
53.92
2.0M 1.20%
Sep 6 54.13 55.47
55.63
51.7
3.8M -2.27%
Sep 5 55.39 57.72
58.38
54.51
2.6M -4.66%
Sep 4 58.1 58.2
60.27
57.57
1.6M -0.5%
Sep 3 58.39 63.7
64.64
58.11
3.2M -8.94%
Aug 30 64.12 62.66
64.91
60.78
2.8M 2.35%
Aug 29 62.65 61.29
64.16
61.25
2.0M 2.44%
Aug 28 61.16 61.17
62.05
60.04
1.7M 0%